Geographic Atrophy Treatment Market is expected to grow steeply with a CAGR of ~30%, companies like Roche, NGM Biopharmaceuticals, Apellis Pharmaceuticals etc among others fueling the market

(Albany, US) DelveInsight's Geographic Atrophy Market Analysis Report proffers a comprehensive outlay of the Geographic Atrophy Epidemiological analysis focusing on the incidence and diagnosed patient pool segmented on the basis of several factors, as well as the Geographic Atrophy market analysis in the 7MM (the US, EU5 (the UK, France, Germany, Italy and Spain) and Japan).

The report covers the Geographic Atrophy market trends covering key pharmaceutical companies in the market, upcoming as well as Geographic Atrophy marketed therapies, unmet needs, prevailing constraints and the factors driving the market size growth.

Know more about Geographic Atrophy Market Report: https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the significant Geographic Atrophy Market Report Highlights:
• Increase in Geographic Atrophy market size anticipated for the study period 2019-2032 at a CAGR of ~30%.
• Globally, more than 5 million people are affected by Geographic Atrophy.
• In the year 2020, the total prevalent case of Geographic Atrophy was 2,969,911 cases in the 7MM. These cases are expected to grow with a significant CAGR in the study period 2019-2032.
• In the 7MM, the total treated cases of Geographic Atrophy were 1,267,314 cases in 2020.
• There are currently no approved Geographic Atrophy treatments. Several major players such as Apellis Pharmaceuticals, NGM Biopharmaceuticals, Roche, and many others are developing therapies for the Geographic Atrophy treatment.
• NGM Biopharmaceuticals is currently conducting the Phase 2 CATALINA study, a multicenter, randomized, double-masked, sham-controlled clinical trial, to assess the safety and efficacy of intravitreal injections (IVT) of NGM621 in patients with Geographic Atrophy secondary to age-related macular degeneration (AMD).
• NGM completed a multi-centre evaluation of NGM621 in an open-label, single-dose, and multiple-dose escalation study in participants with Geographic Atrophy Secondary to Age-related Macular Degeneration (NCT04014777).

Get more comprehensive insights into how Geographic Atrophy epidemiological trends are impacting current and forecasted Geographic Atrophy market @ https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of Geographic Atrophy Companies:
• Iveric Bio (formerly Ophthotech Corporation)
• Apellis Pharmaceuticals
• Hemera Biosciences
• Allegro Ophthalmics
• Stealth BioTherapeutics
• Alkeus Pharmaceuticals
• Gyroscope Therapeutics
• Regenerative Patch Technologies
• Roche/Genentech
• Ionis Pharmaceuticals/Roche
• CellCure Neurosciences (a subsidiary of Lineage Cell Therapeutics)
• Janssen Research & Development
• And Many Others

Do you want to know how much market share the emerging therapies are going to capture by 2032? Contact @ https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

The launch of the emerging therapies is expected to significantly impact the Geographic Atrophy treatment scenario in the upcoming years:-

Some of Geographic Atrophy Drugs Covered:
• Zimura (avacincaptad pegol)
• Pegcetacoplan
• HMR59/AAVCAGsCD59
• Risuteganib/ALG-1001/Luminate
• Elamipretide
• ALK-001
• GT005
• CPCB-RPE1
• RO7171009/RG6147
• IONIS-FB-LRx
• OpRegen
• Palucorcel/CNTO 2476
• And Many Others

Know more about the collaborations, tie-ups, and therapies launch @ https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents:
1. Key Insights
2. Executive Summary of Geographic Atrophy
3. Competitive Intelligence Analysis for Geographic Atrophy
4. Geographic Atrophy: Market Overview at a Glance
5. Geographic Atrophy: Disease Background and Overview
6. Patient Journey
7. Geographic Atrophy Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Geographic Atrophy Treatment
11. Marketed Products
12. Emerging Therapies
13. Geographic Atrophy: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Geographic Atrophy
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities

Request for Free Sample Report: https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Latest Reports:

3D Cardiac Mapping System Market
https://www.delveinsight.com/report-store/3d-cardiac-mapping-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Acanthamoeba Keratitis Market
https://www.delveinsight.com/report-store/acanthamoeba-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Adult Growth Hormone Deficiency Market
https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Advanced Cancer Pain Management Market
https://www.delveinsight.com/report-store/advanced-cancer-pain-management-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Apheresis Market
https://www.delveinsight.com/report-store/apheresis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Arteriovenous fistula Market
https://www.delveinsight.com/report-store/arteriovenous-fistula-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Automated external defibrillators (AEDs) Market
https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Balloon Catheters Market
https://www.delveinsight.com/report-store/balloon-catheters-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Calciphylaxis Market
https://www.delveinsight.com/report-store/calciphylaxis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Cerebral Aneurysm Market
https://www.delveinsight.com/report-store/cerebral-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Chronic Idiopathic Urticaria Market
https://www.delveinsight.com/report-store/chronic-idiopathic-urticaria-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

This release was published on openPR.